SLC1A5 and breast cancer: Multiple studies have indicated that CUR displaysantitumorigenic activity in breast cancer (BC) by inducing ferroptosis, with mechanisms that involve promoting SLC1A5-mediated ferroptosis (107) and inducing HO-1 expression (108, 109).